Default company panoramic image

StableBody Technologies, LLC

SBT is uniquely positioned to bring a new dimension to cancer detection and treatment with renewed hope for cancer patients.

  • Stage $500K in TTM Revenue
  • Industry Biotechnology
  • Location Madison, WI, USA
  • Currency USD
  • Founded October 2009
  • Employees 4
  • Website

Company Summary

SBT uses proprietary bioinformatics and production methodologies to design, optimize, and produce highly functional protein reagents. SBT’s optimized reagents carry the designation CCFr, cold chain free reagent, and do not require refrigeration. Clinical reagents developed with SBT technology have considerable advantages for cancer diagnostics in sensitivity and cost, as well as innovative cancer treatments for the bio-pharmaceutical marketplace.


  • Default avatar
    Joseph Firca

    Co-Founder, a Member, and the Chairman of STABLEBODY TECHNOLOGIES. Dr. Firca is a recognized leader in the life science and biotechnology arena and brings more than 35 years of extensive operating and product development knowledge to STABLEBODY TECHNOLOGIES. In addition to his combined 15 years at Baxter International Inc., and Abbott Laboratories, Dr. Firca has either co-founded or been an integral part of numerous entrepreneurial ventures.

  • Default avatar
    H. Rossiter Horn

    Co-Founder, a Member, and the Chief Executive Officer of STABLEBODY TECHNOLOGIES, overseeing all functions of the company. Mr. Horn has over 25 years experience in the biotech and pharmaceutical industries, working with both large (Fortune 50) and start-up companies. He brings extensive expertise in strategic clinical planning, business development, licensing and project management in the healthcare markets.


  • Default avatar
    Neider and Boucher, S.C.; Casimir Jones, S.C.